Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 47701-47750 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05555433
Calprotectine in Spondyloarthritis
N/ARecruiting
190 participants
Started: Aug 15, 2022 · Completed: Aug 15, 2024
1 condition1 sponsor1 location
NCT05409443
Conventional vs Bipolar SIJ RFA for Treatment of Sacroiliac Joint Pain
PHASE4Recruiting
116 participants
Started: Aug 15, 2022 · Completed: Jun 30, 2027
2 conditions2 sponsors3 locations
NCT05416775
Phase Ib/II Study of SHR-8068 Injection in the Treatment of Advanced Non-small Cell Lung Cancer
PHASE1/PHASE2Recruiting
168 participants
Started: Aug 15, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor18 locations
NCT05486546
Contoura With Phorcides Compared to Wavefront Optimized LASIK
NARecruiting
120 participants
Started: Aug 15, 2022 · Completed: Dec 1, 2023
2 conditions2 sponsors4 locations
NCT05351502
A Study to Assess the Safety and Efficacy of Nitric Oxide Injection Into Unresectable Solid Primary or Metastatic Tumors
PHASE1Recruiting
38 participants
Started: Aug 14, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor4 locations
NCT05596214
Combination of Curcumin and Berberine Therapy in the Treatment of Post Acute Diverticulitis (SUDD)
PHASE2Recruiting
40 participants
Started: Aug 14, 2022 · Completed: May 31, 2025
1 condition1 sponsor1 location
NCT05855252
PRECISION-TBI - An Observational Study of Patients With Moderate to Severe Traumatic Brain Injury
N/ARecruiting
300 participants
Started: Aug 14, 2022 · Completed: Jul 1, 2025
1 condition1 sponsor9 locations
NCT05539638
The Role of Circulating Tumour DNA in Head and Neck Cancer
N/ARecruiting
250 participants
Started: Aug 14, 2022 · Completed: Aug 31, 2027
2 conditions1 sponsor5 locations
NCT06648954
Effect of Multisite High-definition Transcranial Direct Current Stimulation Targeting Sensorimotor Network
NARecruiting
30 participants
Started: Aug 13, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05918107
A Study of PM8002 Injection in Combination With Standard Chemotherapy as First Line Therapy in MPM
PHASE2Recruiting
55 participants
Started: Aug 13, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05484908
Efficacy and Safety of ALSS Treatment for ICIs-LF in Patients With HCC
NARecruiting
60 participants
Started: Aug 12, 2022 · Completed: Dec 31, 2024
3 conditions1 sponsor1 location
NCT05673499
International Study of Cerebral Oxygenation and Electrical Activity During Major Neonatal Surgery
N/ARecruiting
900 participants
Started: Aug 12, 2022 · Completed: Dec 31, 2027
3 conditions2 sponsors15 locations
NCT05996653
CEST in Low-grade Glioma Study
NARecruiting
100 participants
Started: Aug 12, 2022 · Completed: Aug 12, 2028
1 condition1 sponsor2 locations
NCT05506410
A Clinical Study of Hanlikang and BTK Inhibitors in the Treatment of Newly Diagnosed Mantle Cell Lymphoma
N/ARecruiting
100 participants
Started: Aug 12, 2022 · Completed: Dec 30, 2026
1 condition1 sponsor1 location
NCT05317858
Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets
PHASE3Recruiting
30 participants
Started: Aug 12, 2022 · Completed: Dec 1, 2027
2 conditions1 sponsor7 locations
NCT05651178
Human CD19-CD22 Targeted T Cells Injection for Refractory/Relapsed Central Nervous System Leukemia/Lymphoma Patients
EARLY_PHASE1Recruiting
10 participants
Started: Aug 12, 2022 · Completed: Aug 31, 2025
1 condition2 sponsors1 location
NCT05502770
Development of IVF/ICSI Children Born From Different Endometrial Preparation Protocols
N/ARecruiting
700 participants
Started: Aug 12, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05738408
Remote Smoking Cessation in Hospitalized Cardiac Patients
NARecruiting
50 participants
Started: Aug 12, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05227326
AOH1996 for the Treatment of Refractory Solid Tumors
PHASE1Recruiting
92 participants
Started: Aug 12, 2022 · Completed: Sep 13, 2029
7 conditions2 sponsors2 locations
NCT05357651
A Study to Assess the Safety and Efficacy of LB1410 in Participants With Advanced Solid Tumor or Lymphoma(Keyplus-001)
PHASE1Recruiting
100 participants
Started: Aug 12, 2022 · Completed: Dec 30, 2028
2 conditions1 sponsor1 location
NCT06217588
LCAT (Lecithin Cholesterol Acyl Transferase) Natural History Study
N/ARecruiting
40 participants
Started: Aug 12, 2022 · Completed: Aug 31, 2028
1 condition1 sponsor1 location
NCT05593107
68Ga-N188 PET/CT Imaging in Malignancy
NARecruiting
203 participants
Started: Aug 12, 2022 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT05344209
Efficacy and Safety of Anti-PD-1/PD-L1 Treatment +/- UV1 Vaccination in Patients With Non-small Cell Lung Cancer
PHASE2Recruiting
138 participants
Started: Aug 12, 2022 · Completed: Jul 1, 2027
3 conditions11 sponsors1 location
NCT05421663
A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma
PHASE1/PHASE2Recruiting
385 participants
Started: Aug 12, 2022 · Completed: Dec 29, 2028
3 conditions1 sponsor30 locations
NCT05826457
North American Prodromal Synucleinopathy Consortium Stage 2
N/ARecruiting
500 participants
Started: Aug 12, 2022 · Completed: May 1, 2025
6 conditions12 sponsors9 locations
NCT05383287
Characteristics, Phenotypes, and TRAITS of Heart Failure With Preserved Ejection Fraction (TRAITS-HFpEF)
N/ARecruiting
1,250 participants
Started: Aug 12, 2022 · Completed: Oct 31, 2029
1 condition1 sponsor1 location
NCT04875884
Optimized MRI of Patients With Hip Arthroplasty
NARecruiting
22 participants
Started: Aug 11, 2022 · Completed: Dec 30, 2027
1 condition3 sponsors1 location
NCT05050903
Early Antiviral Responses to Rhinovirus Infection in Asthma
N/ARecruiting
40 participants
Started: Aug 11, 2022 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT05339074
Maintenance Ketamine Infusions for Treatment-Resistant Bipolar Depression
PHASE2Recruiting
60 participants
Started: Aug 11, 2022 · Completed: Feb 28, 2026
4 conditions1 sponsor3 locations
NCT05194111
Treating Heart Dysfunction Related to Cancer Therapy With Sacubitril/Valsartan
PHASE1/PHASE2Recruiting
53 participants
Started: Aug 11, 2022 · Completed: Nov 30, 2026
2 conditions1 sponsor1 location
NCT05480735
EffectiveNess of a Multimodal preHAbilitation Program in patieNts With Bladder canCEr Undergoing Cystectomy
NARecruiting
154 participants
Started: Aug 11, 2022 · Completed: Oct 31, 2025
1 condition9 sponsors8 locations
NCT05078970
Advancing Suicide Intervention Strategies for Teens During High Risk Periods
NARecruiting
306 participants
Started: Aug 11, 2022 · Completed: Aug 1, 2026
4 conditions2 sponsors2 locations
NCT05327465
Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy
NARecruiting
62 participants
Started: Aug 11, 2022 · Completed: Jun 30, 2026
3 conditions3 sponsors1 location
NCT05232916
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
PHASE3Recruiting
750 participants
Started: Aug 11, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor161 locations
NCT05111574
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
PHASE2Recruiting
99 participants
Started: Aug 11, 2022 · Completed: Dec 19, 2025
17 conditions1 sponsor146 locations
NCT05700825
Rehabilitation of Airway Protection in Parkinson's Disease
PHASE2Recruiting
120 participants
Started: Aug 11, 2022 · Completed: Sep 1, 2027
2 conditions3 sponsors2 locations
NCT05299008
The Effect of Bethanechol on Tracheobronchomalacia
N/ARecruiting
20 participants
Started: Aug 11, 2022 · Completed: Jun 30, 2024
1 condition1 sponsor1 location
NCT05611502
Influence of TMS on Attention Modulation
NARecruiting
40 participants
Started: Aug 11, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05439889
Follow-up Study on Chronic Myeloid Leukemia Patients Achieving Treatment-free Remission
N/ARecruiting
100 participants
Started: Aug 11, 2022 · Completed: Aug 11, 2032
1 condition1 sponsor1 location
NCT05368298
SCOOT: Sample Collection for DART
N/ARecruiting
5,000 participants
Started: Aug 11, 2022 · Completed: Dec 31, 2025
1 condition8 sponsors10 locations
NCT05580445
Safety, Pharmacokinetics and Efficacy of CT-707, Toripalimab and Gemcitabine in Advanced Pancreatic Cancer
PHASE1/PHASE2Recruiting
114 participants
Started: Aug 11, 2022 · Completed: Aug 11, 2024
1 condition1 sponsor1 location
NCT05258396
Exploring Cortical Remyelination in Children With Multiple Sclerosis
NARecruiting
40 participants
Started: Aug 11, 2022 · Completed: Sep 11, 2025
1 condition1 sponsor3 locations
NCT05470348
A Study of BL-B01D1 in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors
PHASE1Recruiting
36 participants
Started: Aug 11, 2022 · Completed: Dec 31, 2027
2 conditions3 sponsors2 locations
NCT05198323
A Study to Evaluate the Safety and Efficacy of LT3001 Drug Product in Subjects AIS Undergoing EVT
PHASE2Recruiting
66 participants
Started: Aug 11, 2022 · Completed: Mar 31, 2026
1 condition1 sponsor2 locations
NCT05509725
Efficacy and Safety of a Probiotic Formulation in Adults With Irritable Bowel Syndrome With Diarrhea (IBS-D)
PHASE4Recruiting
162 participants
Started: Aug 11, 2022 · Completed: Nov 30, 2024
1 condition1 sponsor1 location
NCT05266222
Respiratory Virus Sampling and Repository
N/ARecruiting
20,000 participants
Started: Aug 11, 2022 · Completed: Dec 31, 2031
2 conditions1 sponsor2 locations
NCT05466708
Safety and Efficacy of Esketamine Combined With Dexmedetomidine for Sedation of Mechanically Ventilated Patients
PHASE4Recruiting
100 participants
Started: Aug 11, 2022 · Completed: Dec 1, 2024
5 conditions1 sponsor1 location
NCT05431270
Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 MAb, Administered Alone and in Combination with a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)
PHASE1/PHASE2Recruiting
40 participants
Started: Aug 11, 2022 · Completed: Aug 31, 2028
2 conditions2 sponsors6 locations
NCT06310954
Ketogenic Diet in Pediatric Intractable Epilepsy
NARecruiting
59 participants
Started: Aug 11, 2022 · Completed: Apr 30, 2024
2 conditions1 sponsor1 location
NCT04834388
Studying Anakinra to Reduce Secondary Brain Damage After Spontaneous Haemorrhagic Stroke
PHASE2Recruiting
75 participants
Started: Aug 10, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location